Clinical Trials Logo

Clinical Trial Details — Status: Completed

Administrative data

NCT number NCT03810885
Other study ID # H-17030995
Secondary ID
Status Completed
Phase N/A
First received
Last updated
Start date February 1, 2018
Est. completion date April 30, 2019

Study information

Verified date July 2019
Source Bispebjerg Hospital
Contact n/a
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

The trial is conducted as a randomized controlled trial including children and adults recruited as families. The families are randomly allocated into three groups to investigate the effect of different salt reduction strategies in a period of 3-4 months. Families in the first intervention group are receiving salt reduced bread. Families in the second intervention group are receiving salt reduced bread in combination with dietary counselling to reduce salt and increase potassium intake. Families in the control group are receiving bread with a regular content of salt and no dietary counselling.


Description:

The trial is conducted as a randomized controlled trial including children and adults recruited as families. The families are randomly allocated into three groups to investigate the effect of different salt reduction strategies in a period of 3-4 months. Families in the first intervention group are receiving salt reduced bread. Families in the second intervention group are receiving salt reduced bread in combination with dietary counselling to reduce salt and increase potassium intake. Families in the control group are receiving bread with a regular content of salt and no dietary counselling.

Participants will be instructed to replace their usual consumption of bread by the bread products provided in the study. In all other respects, participants will be requested to live their lives as usual without changing any habits, except the families receiving dietary counselling. The participants will be unaware of the treatment groups and the salt content of the bread products will be blinded to the participants.

Families will attend a physical examination at baseline and at 3-4 months follow-up. The health examination includes anthropometrics, blood pressure measurements and blood samplings for analysis of glucose, lipid metabolism and hormone balance. Urine samples will be collected to investigate the sodium and potassium content. Furthermore salt-sensitivity and preference tests will be made. After both health examinations the families will collect three repeated 24-hour urine collections at home and fill in a 7 days dietary record.

After data collection, blood and urine samples will be analysed. Analyses from both baseline and follow-up are expected ultimo February 2019, whereby data cleaning and statistical analyses will be performed.


Recruitment information / eligibility

Status Completed
Enrollment 316
Est. completion date April 30, 2019
Est. primary completion date April 30, 2019
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 3 Years to 69 Years
Eligibility Inclusion Criteria:

- Participants living with children

- Adults 18-69 years

- Children 3-17 years

- Daily intake of bread

Exclusion Criteria:

- Diabetes

- Cardiovascular disease

- Antihypertensive treatment

- Lipid-lowering treatment

- Pregnancy

- U-albumin > 300 mg/day

- Celiac disease

Study Design


Related Conditions & MeSH terms


Intervention

Other:
Bread with reduced salt content
Bread with gradually lowered salt content
Behavioral:
Dietary advice
Participants will receive information on how to lower salt and increase potassium intake
Other:
Bread with standard salt content
Bread with normal salt content

Locations

Country Name City State
Denmark Center fot Clinical Research and Prevention Glostrup Capital Region

Sponsors (1)

Lead Sponsor Collaborator
Bispebjerg Hospital

Country where clinical trial is conducted

Denmark, 

Outcome

Type Measure Description Time frame Safety issue
Other Change from Baseline Glucose levels in plasma at 4 months blood sampled, with the participant lying down after 30 minutes of rest. Minimum 2 hours of fasting. Measurements at Baseline and at 4 month.
Other Change from Baseline HbA1C levels in full blood at 4 months blood sampled, with the participant lying down after 30 minutes of rest. Minimum 2 hours of fasting. Measurements at Baseline and at 4 month.
Other Change from Baseline Cholesterol levels in plasma (LDL, HDL, total cholesterol and triglycerides) at 4 months blood sampled, with the participant lying down after 30 minutes of rest. Minimum 2 hours of fasting. Measurements at Baseline and at 4 month.
Other Change from Baseline Height in centimetres at 4 months Measured in centimetres to the closest decimal, without shoes or socks, with clothes on Measurements at Baseline and at 4 month.
Other Change from Baseline Weight in kilograms at 4 months Measured in kilograms to the closest decimal, without shoes or socks, with clothes on Measurements at Baseline and at 4 month.
Other Change from Baseline Impedance in ohm at 4 months Measured in ohm to the closest decimal, without shoes or socks, with clothes on Measurements at Baseline and at 4 month.
Other Change from Baseline Hip circumference in centimetres at 4 months Measured on bare skin to nearest decimal Measurements at Baseline and at 4 month.
Other Change from Baseline Waist circumference in centimetres at 4 months Measured on bare skin to nearest decimal Measurements at Baseline and at 4 month.
Other Baseline Albumin in spot urine Not morning urine, minimum 2 hours of fasting Measurements at Baseline
Other Change from Baseline Sodium, potassium and creatinine level in spot urine at 4 months Not morning urine, minimum 2 hours of fasting Measurements at Baseline and at 4 month.
Primary Change from Baseline sodium level in 24 hour urine at 4 months Adults average of 3 repeated 24 hour urine, children a single 24hour urine collection; excluding urine first morning including urine of the following morning. Completeness evaluated in adults by Para-Amino-Benzoic-Acid (PABA). Measurements at Baseline and at 4 month.
Secondary Change from Baseline potassium level in 24 hour urine at 4 months Adults average of 3 repeated 24 hour urine, children a single 24hour urine collection; excluding urine first morning including urine of the following morning. Measurements at Baseline and at 4 month.
Secondary Change from Baseline Systolic blood pressure at 4 months Systolic blood pressure measured at baseline and follow-up . Average of three measurements, with the participant sitting upright at rest.. Minimum 2 hours fasting. Measurements at Baseline and at 4 month.
Secondary Change from Baseline Diastolic blood pressure at 4 months Diastolic blood pressure measured at baseline and follow-up . Average of three measurements, with the participant sitting upright at rest.. Minimum 2 hours fasting. Measurements at Baseline and at 4 month.
Secondary Change from Baseline Adrenaline and Noradrenaline levels in plasma at 4 months blood sampled, stored on ice, with the participant lying down after 30 minutes of rest. Minimum 2 hours of fasting. Measurements at Baseline and at 4 month.
Secondary Change from Baseline Renin and Aldosterone levels in plasma at 4 months blood sampled, with the participant lying down after 30 minutes of rest. Minimum 2 hours of fasting. Measurements at Baseline and at 4 month.
Secondary Change from Baseline Salt sensitivity and preference at 4 months Sensory test: Sensitivity and preference test, minimum 2 hours of fasting Measurements at Baseline and at 4 month.
See also
  Status Clinical Trial Phase
Terminated NCT02261688 - Salt and TH-17 in Healthy Human Subjects N/A
Not yet recruiting NCT03871374 - Factors Affecting Salt Intake in Young Adults
Completed NCT05792241 - Acceptability and Nutritional Impact of Double-fortified Salt Containing Iodine and Folic Acid - Phase 1
Recruiting NCT03467568 - Does Salt Intake Improve Mood N/A
Active, not recruiting NCT06223854 - Acceptability and Nutritional Impact of Double-fortified Salt Containing Iodine and Folic Acid N/A